9 Meters Biopharma Inc NMTR:NASDAQ

Last Price$0.93NASDAQ Previous Close - Last Trade as of 4:00PM ET 12/03/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$0.93 (6)
Ask (Size)$0.96 (5)
Day Low / HighN/A - N/A
Volume2.1 M

View Biotechnology IndustryPeer Comparison as of 12/03/2021


9 Meters Biopharma Inc ( NASDAQ )

Price: $0.93
Change: -0.01 (1.09%)
Volume: 2.1 M
4:00PM ET 12/03/2021

Fortress Biotech Inc ( NASDAQ )

Price: $2.42
Change: -0.23 (8.68%)
Volume: 935.4 K
4:00PM ET 12/03/2021

Co-Diagnostics Inc ( NASDAQ )

Price: $8.35
Change: -0.08 (0.95%)
Volume: 505.8 K
4:00PM ET 12/03/2021

Surface Oncology Inc ( NASDAQ )

Price: $5.24
Change: -0.39 (6.93%)
Volume: 697.1 K
4:00PM ET 12/03/2021

Athersys Inc ( NASDAQ )

Price: $1.03
Change: -0.06 (5.50%)
Volume: 1.8 M
4:00PM ET 12/03/2021

Read more news Recent News

--Oppenheimer Adjusts 9 Meters Biopharma PT to $5 From $5.50, Maintains Outperform Rating
10:24AM ET 11/16/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

9 Meters Biopharma, EBRIS Foundation Team Up in Mid-Stage Study of Inflammatory Syndrome Treatment Candidate
10:22AM ET 8/16/2021 MT Newswires

9 Meters Biopharma (NMTR) said Monday it entered into a collaboration with Italy-based European Biomedical Research Institute of Salerno, or EBRIS, in a...

9 Meters Acquires LOB-0136 Antibody from Lobesity
11:03AM ET 7/19/2021 MT Newswires

9 Meters Biopharma (NMTR) said Monday it has purchased the global development rights to LOB-0136, including the related intellectual property, from...

BMO Capital Initiates 9 Meters Biopharma at Outperform Rating With $5 Price Target
8:34AM ET 7/08/2021 MT Newswires

9 Meters Biopharma (NMTR) has an average outperform rating and a price target range of $3 to $6, according to analysts polled by Capital IQ. (MT Newswires...

View all Commentary and Analysis

9 Meters Biopharma Inc (NMTR) Investor Presentation - Slideshow
2:16PM ET 9/10/2021 Seeking Alpha

Finding Abnormal Returns With The Russell Index Rebalancing Every June
8:39AM ET 5/24/2021 Seeking Alpha

Company Profile

Business Description9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC. View company web site for more details
Address8480 Honeycutt Road
Raleigh, North Carolina 27615
Number of Employees8
Recent SEC Filing12/03/20214
President, Chief Executive Officer & DirectorJohn Temperato
SVP-Corporate Development & OperationsSireesh Appajosyula
Chief Financial & Accounting OfficerEdward J. Sitar
Chief Medical OfficerPatrick H. Griffin

Company Highlights

Price Open$0.98
Previous Close$0.94
52 Week Range$0.68 - 2.26
Market Capitalization$237.3 M
Shares Outstanding255.7 M
SectorHealth Technology
Next Earnings Announcement03/28/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.12
Beta vs. S&P 500N/A
Net Profit MarginN/A
Return on Equity-73.73%

Analyst Ratings as of 11/20/2021

Consensus RecommendationConsensus Icon
Powered by Factset